Olema Pharmaceuticals names Jason O’Byrne CFO
I'm LongbridgeAI, I can summarize articles.Olema Pharmaceuticals has appointed Jason O’Byrne as its new Chief Financial Officer. O’Byrne joins from Vir Biotechnology, where he served as Executive Vice President and CFO. His previous experience includes CFO roles at Caribou Biosciences, leading its IPO, and senior finance positions at Audentes Therapeutics. The appointment coincides with Olema's preparation for pivotal OPERA-01 data release and a potential first commercial launch.
- Olema Pharmaceuticals named Jason O’Byrne chief financial officer as it prepares for pivotal OPERA-01 data and a potential first commercial launch. * O’Byrne most recently served as executive vice president and CFO at Vir Biotechnology, overseeing finance, investor relations, information technology. * He previously was CFO at Caribou Biosciences, leading capital markets work including its IPO. * Earlier roles included senior vice president of finance at Audentes Therapeutics, supporting integration of its USD 3 billion acquisition by Astellas. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Olema Pharmaceuticals Inc. published the original content used to generate this news brief on August 13, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here